Xueyuan Bai

8.5k total citations
77 papers, 1.9k citations indexed

About

Xueyuan Bai is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Xueyuan Bai has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 22 papers in Nephrology and 15 papers in Epidemiology. Recurrent topics in Xueyuan Bai's work include Renal and related cancers (20 papers), Autophagy in Disease and Therapy (15 papers) and Chronic Kidney Disease and Diabetes (13 papers). Xueyuan Bai is often cited by papers focused on Renal and related cancers (20 papers), Autophagy in Disease and Therapy (15 papers) and Chronic Kidney Disease and Diabetes (13 papers). Xueyuan Bai collaborates with scholars based in China, United States and Philippines. Xueyuan Bai's co-authors include Xiangmei Chen, Guangyan Cai, Quan Hong, Suozhu Shi, Bo Fu, Xiangmei Chen, Shaoyuan Cui, Zhe Feng, Rui Ding and Xuefeng Sun and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Bioresource Technology.

In The Last Decade

Xueyuan Bai

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueyuan Bai China 27 846 376 335 327 283 77 1.9k
Wei Tang China 27 1.0k 1.2× 363 1.0× 251 0.7× 254 0.8× 291 1.0× 73 2.5k
Syamantak Majumder India 23 818 1.0× 257 0.7× 182 0.5× 245 0.7× 147 0.5× 67 1.8k
Qun Dai United States 22 1.0k 1.2× 233 0.6× 257 0.8× 149 0.5× 150 0.5× 61 2.1k
Jinhua Tang China 21 922 1.1× 396 1.1× 206 0.6× 139 0.4× 202 0.7× 44 1.9k
Amaneh Mohammadi Roushandeh Iran 26 918 1.1× 227 0.6× 350 1.0× 129 0.4× 192 0.7× 102 2.0k
Dan Zhao China 28 1.2k 1.4× 180 0.5× 566 1.7× 124 0.4× 161 0.6× 118 2.3k
Samy L. Habib United States 24 1.0k 1.2× 114 0.3× 297 0.9× 298 0.9× 151 0.5× 72 1.8k
You Li China 23 1.1k 1.3× 144 0.4× 729 2.2× 165 0.5× 200 0.7× 79 2.4k
Chunyuan Guo China 20 798 0.9× 216 0.6× 298 0.9× 112 0.3× 111 0.4× 41 2.0k
Mehmet M. Altintas United States 20 982 1.2× 1.5k 4.0× 207 0.6× 255 0.8× 220 0.8× 45 2.7k

Countries citing papers authored by Xueyuan Bai

Since Specialization
Citations

This map shows the geographic impact of Xueyuan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyuan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyuan Bai more than expected).

Fields of papers citing papers by Xueyuan Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyuan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyuan Bai. The network helps show where Xueyuan Bai may publish in the future.

Co-authorship network of co-authors of Xueyuan Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyuan Bai. A scholar is included among the top collaborators of Xueyuan Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyuan Bai. Xueyuan Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Jing, Yingjie Zhang, C. Li, et al.. (2025). Cxcl9high macrophages recruit circulating Cxcr3+ plasmablasts into kidneys to promote pathogenesis of lupus nephritis mice. Communications Biology. 8(1). 1446–1446.
2.
Li, Xiaofan, Jianwen Chen, Jun‐Xu Li, et al.. (2025). ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD. Molecular Therapy. 33(2). 805–822. 7 indexed citations
3.
Chen, Yulan, Xueyuan Bai, Jianwen Chen, et al.. (2023). Pyruvate kinase M2 regulates kidney fibrosis through pericyte glycolysis during the progression from acute kidney injury to chronic kidney disease. Cell Proliferation. 57(2). e13548–e13548. 22 indexed citations
4.
Li, Xiaofan, Yiyao Deng, Jianwen Chen, et al.. (2023). The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII. Journal of Translational Medicine. 21(1). 323–323. 25 indexed citations
6.
Cui, Shaoyuan, Quan Hong, Wanjun Shen, et al.. (2022). Role of NOD-Like Receptors in a Miniature Pig Model of Diabetic Renal Injuries. Mediators of Inflammation. 2022. 1–9. 4 indexed citations
7.
Zhang, Yingjie, Wanjun Shen, Fei Zhu, et al.. (2020). Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice. BioMed Research International. 2020(1). 7469428–7469428. 1 indexed citations
8.
Deng, Luchan, Hongling Li, Xiaodong Su, et al.. (2020). Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation. Cell Death and Disease. 11(3). 158–158. 21 indexed citations
9.
Cui, Jing, Xueyuan Bai, & Xiangmei Chen. (2020). Autophagy and Diabetic Nephropathy. Advances in experimental medicine and biology. 1207. 487–494. 23 indexed citations
10.
Zhao, Jing, Yuxiang Ma, Yingjie Zhang, et al.. (2019). Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism. Cell Death Discovery. 5(1). 76–76. 40 indexed citations
11.
Bai, Xueyuan, Quan Hong, Shaoyuan Cui, et al.. (2019). STAT3 Inhibition Partly Abolishes IL-33–Induced Bone Marrow–Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis. The Journal of Immunology. 203(10). 2644–2654. 7 indexed citations
12.
Wu, Xiao‐Yuan, Yingjie Zhang, Kangkang Song, et al.. (2018). The combination of metformin and 2‐deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease. British Journal of Pharmacology. 176(5). 711–724. 53 indexed citations
13.
Cui, Shaoyuan, Qing Ouyang, Yan Mei, et al.. (2018). Modulation of Macrophage Polarization by Human Glomerular Mesangial Cells in Response to the Stimuli in Renal Microenvironment. Journal of Interferon & Cytokine Research. 38(12). 566–577. 10 indexed citations
14.
Song, Fei, Yuxiang Ma, Xueyuan Bai, & Xiangmei Chen. (2015). The Expression Changes of Inflammasomes in the Aging Rat Kidneys. The Journals of Gerontology Series A. 71(6). 747–756. 26 indexed citations
15.
Shi, Suozhu, Ping Zhang, Qingli Cheng, et al.. (2013). Immunohistochemistry of deparaffinised sections using antigen retrieval with microwave combined pressure cooking versus immunofluorescence in the assessment of human renal biopsies. Journal of Clinical Pathology. 66(5). 374–380. 5 indexed citations
16.
Ye, Jianhua, Jin He, Qiuyan Li, et al.. (2013). Generation of c-Myc transgenic pigs for autosomal dominant polycystic kidney disease. Transgenic Research. 22(6). 1231–1239. 6 indexed citations
17.
Ning, Yichun, Guangyan Cai, Jianjun Gao, et al.. (2013). Short-term calorie restriction protects against renal senescence of aged rats by increasing autophagic activity and reducing oxidative damage. Mechanisms of Ageing and Development. 134(11-12). 570–579. 72 indexed citations
18.
Bai, Xueyuan. (2004). Expression of EGFP/SDCT1 fusion protein, subcellular localization signal analysis, tissue distribution and electrophysiological function study. Science in China Series C Life Sciences. 47(6). 530–530. 4 indexed citations
19.
Bai, Xueyuan. (2002). Effect of p19ARF on growth and apoptosis of leukemia cells. Zhongguo bingli shengli zazhi.
20.
Bai, Xueyuan, et al.. (1998). Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Gene Therapy. 5(7). 984–994. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026